[1. W. Sneader, Drug Discovery. A History, John Wiley & Sons, Chichester 2005.10.1002/0470015535]Search in Google Scholar
[2. D. T. Courtwright, Forces of Habit – Drugs and the Making of the Modern World, Harvard University Press, Cambridge (MA) 2002.10.4159/9780674029903]Search in Google Scholar
[3. M. Hanada, Case Studies in Modern Drug Discovery and Development, John Wiley & Sons, Hoboken (NJ) 2012.]Search in Google Scholar
[4. D. A. Dias, S. Urban and U. Roessner, A historical overview of natural products in drug discovery, Metabolites2 (2012) 303–336; https://doi.org/10.3390/metabo202030310.3390/metabo2020303390120624957513]Search in Google Scholar
[5. M. Friedman, Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (Lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds, J. Agric. Food Chem. 63 (2015) 7108–7123; https://doi.org/10.1021/acs.jafc.5b0291410.1021/acs.jafc.5b0291426244378]Search in Google Scholar
[6. X. He, X. Wang, J. Fang, Y. Chang, N. Ning, H. Guo, L. Huang, X. Huang and Z. Zhao, Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s mane) mushroom: A review, Int. J. Biol. Macromol. 97 (2017) 228–237; https://doi.org/10.1016/j.ijbiomac.2017.01.04010.1016/j.ijbiomac.2017.01.04028087447]Search in Google Scholar
[7. G. Wang, X. Zhang, S. E. Maier, L. Zhang and R. J. Maier, In vitro and in vivo inhibition of Helicobacter pylori by ethanolic extracts of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), Int. J. Med. Mushrooms21 (2019) 1–11; https://doi.org/10.1615/IntJMedMush-rooms.201802948710.1615/IntJMedMushrooms.2018029487]Search in Google Scholar
[8. M. Qin, Y. Geng, Z. Lu, H. Xu, J. S. Shi, X. Xu and Z. H. Xu, Antiinflammatory effects of ethanol extract of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), in mice with ulcerative colitis, Int. J. Med. Mushrooms18 (2016) 227–234; https://doi.org/10.1615/IntJMedMush-rooms.v18.i3.5010.1615/IntJMedMushrooms.v18.i3.50]Search in Google Scholar
[9. M. Wang, T. Konishi, Y. Gao, D. Xu and Q. Gao, Anti-gastric ulcer activity of polysaccharide fraction isolated from mycelium culture of Lion’s mane medicinal mushroom, Hericium erinaceus (higher Basidiomycetes), Int. J. Med. Mushrooms17 (2015) 1055–1060; https://doi.org/10.1615/intjmedmushrooms.v17.i11.5010.1615/IntJMedMushrooms.v17.i11.50]Search in Google Scholar
[10. W. Li, W. Zhou, E. J. Kim, S. H. Shim, H. K. Kang and Y. H. Kim, Isolation and identification of aromatic compounds in Lion’s Mane Mushroom and their anticancer activities, Food Chem. 170 (2015) 336–342; https://doi.org/10.1016/j.foodchem.2014.08.07810.1016/j.foodchem.2014.08.07825306354]Search in Google Scholar
[11. S. P. Kim, M. Y. Kang, Y. H. Choi, J. H. Kim, S. H. Nam and M. Friedman, Mechanism of Hericium erinaceus (yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells, Food Funct.2 (2011) 348–356; https://doi.org/10.1039/c1fo10030k10.1039/c1fo10030k21779573]Search in Google Scholar
[12. M. Wang, Y. Zhang, X. Xiao, D. Xu, Y. Gao and Q. Gao, A polysaccharide isolated from mycelia of the Lion’s mane medicinal mushroom Hericium erinaceus (Agaricomycetes) induced apoptosis in precancerous human gastric cells, Int. J. Med. Mushrooms19 (2017) 1053–1060; https://doi.org/10.1615/IntJMedMushrooms.201702497510.1615/IntJMedMushrooms.201702497529431066]Search in Google Scholar
[13. X. Zan, F. Cui, Y. Li, Y. Yang, D. Wu, W. Sun and L. Ping, Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis, Int. J. Biol. Macromol. 76 (2015) 242–253; https://doi.org/10.1016/j.ijbiomac.2015.01.06010.1016/j.ijbiomac.2015.01.06025703932]Search in Google Scholar
[14. Y. Li, G. Zhang, T. B. Ng and H. Wang, A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum, J. Biomed. Biotechnol.2010 (2010) Article ID 716515 (9 pages); https://doi.org/10.1155/2010/71651510.1155/2010/716515]Search in Google Scholar
[15. S. S. Han, C. K. Cho, Y. W. Lee and H. S. Yoo, Antimetastatic and immunomodulating effect of water extracts from various mushrooms, J. Acupunct. Meridian Stud.2 (2009) 218–227; https://doi.org/10.1016/S2005-2901(09)60058-310.1016/S2005-2901(09)60058-3]Search in Google Scholar
[16. X. Sheng, J. Yan, Y. Meng, Y. Kang, Z Han, G. Tai, Y. Zhou and H. Cheng, Immunomodulatory effects of Hericium erinaceus derived polysaccharides are mediated by intestinal immunology, Food Funct.8 (2017) 1020–1027; https://doi.org/10.1039/c7fo00071e10.1039/C7FO00071E28266682]Search in Google Scholar
[17. I.-C. Li, L.-Y. Lee, T.-T. Tzeng, W.-P. Chen, Y.-P. Chen, Y.-J. Shiao and C.-C. Chen, Neurohealth properties of Hericium erinaceus mycelia enriched with erinacines, Behav. Neurol.2018 (2018) 5802634 (10 pages); https://doi.org/10.1155/2018/580263410.1155/2018/5802634598723929951133]Search in Google Scholar
[18. P. Rossi, V. Cesaroni, F. Brandalise, A. Occhinegro, D. Ratto, F. Perrucci, V. Lanaia, C. Girometta, G. Orrù and E. Savino, Dietary supplementation of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), and spatial memory in wild-type mice, Int. J. Med. Mushrooms20 (2018) 485–494; https://doi.org/10.1615/IntJMedMushrooms.201802624110.1615/IntJMedMushrooms.201802624129953363]Search in Google Scholar
[19. P. S. Liu, S. H. Chueh, C. C. Chen, L. Y. Lee and L. Y. Shiu, Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), modulates purinoceptor-coupled calcium signaling and murine nociceptive behavior, Int. J. Med. Mushrooms19 (2017) 499–507; https://doi.org/10.1615/IntJMedMushrooms.v19.i6.2010.1615/IntJMedMushrooms.v19.i6.2029199560]Search in Google Scholar
[20. C.-C. Zhang, X. Yin, C.-Y. Cao, J. Wei, Q. Zhang and J.-M. Gao, Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells, Bioorg. Med. Chem. Lett.25 (2015) 5078–5082; https://doi.org/10.1016/j.bmcl.2015.10.01610.1016/j.bmcl.2015.10.01626481911]Search in Google Scholar
[21. K. Mori, S. Inatomi, K. Ouchi, Y. Azumi and T. Tuchida, Improving effects of the mushroom yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial, Phytother. Res.23 (2009) 367–372; https://doi.org/10.1002/ptr.263410.1002/ptr.263418844328]Search in Google Scholar
[22. M. Nagano, K. Shimizu, R. Kondo, C. Hayashi, D. Sato, K. Kitagawa and K. Ohnuki, Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomed. Res.31 (2010) 231–237; https://doi.org/10.2220/biomedres.31.23110.2220/biomedres.31.23120834180]Search in Google Scholar
[23. A. Blagodatski, M. Yatsunskaya, V. Mikhailova, V. Tiasto, A. Kagansky and V. L. Katanaev, Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy, Oncotarget9 (2018) 29259–29274; https://doi.org/10.18632/oncotarget.2566010.18632/oncotarget.25660604437230018750]Search in Google Scholar
[24. L. J. Standish, C. A. Wenner, E. S. Sweet, C. Bridge, A. Nelson, M. Martzen, J. Novack and C. Torkelson, Trametes versicolor mushroom immune therapy in breast cancer, J. Soc. Integr. Oncol.6 (2008) 122–128.]Search in Google Scholar
[25. K. Oba, S. Teramukai, M. Kobayashi, T. Matsui, Y. Kodera and J. Sakamoto, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer, Cancer Immunol. Immunother.56 (2007) 905–911; https://doi.org/10.1007/s00262-006-0248-110.1007/s00262-006-0248-117106715]Search in Google Scholar
[26. J. Sakamoto, S. Morita, K. Oba, T. Matsui, M. Kobayashi, H. Nakazato and Y. Ohashi, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials, Cancer Immunol. Immunother. 55 (2006) 404–411; https://doi.org/10.1007/s00262-005-0054-110.1007/s00262-005-0054-116133112]Search in Google Scholar
[27. K. Sugimachi, K. Inokuchi and H. Matsuura, Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival, Jpn. J. Surg.14 (1984) 217–221.10.1007/BF024695716748393]Search in Google Scholar
[28. Y. Iino, T. Yokoe, M. Maemura, J. Horiguchi, H. Takei, S. Ohwada and Y. Morishita, Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer, Anticancer Res. 15 (1995) 2907–2911.]Search in Google Scholar
[29. L. Zhong, P. Yan, W. C. Lam, L. Yao and Z. Bian, Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: A systematic review and meta-analysis of randomized controlled trials, Front. Pharmacol. 10 (2019) 703 (14 pages); https://doi.org/10.3389/fphar.2019.0070310.3389/fphar.2019.00703661631031333449]Search in Google Scholar
[30. H. Lu, Y. Yang, E. Gad, C. Inatsuka, C. A. Wenner, M. L. Disis and L. J. Standish, TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy, Clin. Cancer Res. 17 (2011) 6742–6753; https://doi.org/10.1158/1078-0432.CCR-11-114210.1158/1078-0432.CCR-11-1142320698721918170]Search in Google Scholar
[31. H. Lu, Y. Yang, E. Gad, C. A. Wenner, A. Chang, E. R. Larson, Y. Dang, M. Martzen, L. J. Standish and M. L. Disis, Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells, Clin. Cancer Res. 17 (2011) 67–76; https://doi.org/10.1158/1078-0432.CCR-10-176310.1158/1078-0432.CCR-10-1763301724121068144]Search in Google Scholar
[32. K. Quayle, C. Coy, L. Standish and H. Lu, The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan, J. Nat. Med. 69 (2015) 198–208; https://doi.org/10.1007/s11418-014-0879-z10.1007/s11418-014-0879-z25510899]Search in Google Scholar
[33. Z. Wang, B. Dong, Z. Feng, S. Yu and Y. Bao, A study on immunomodulatory mechanism of polysaccharopeptide mediated by TLR4 signaling pathway, BMC Immunol. 16 (2015) Article ID 34 (9 pages); https://doi.org/10.1186/s12865-015-0100-510.1186/s12865-015-0100-5445099426032186]Search in Google Scholar
[34. H. Dou, Y. Chang and L. Zhang, Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Prog. Mol. Biol. Transl. Sci. 163 (2019) 361–381; https://doi.org/10.1016/bs.pmbts.2019.03.00110.1016/bs.pmbts.2019.03.00131030754]Search in Google Scholar
[35. Y. Chang, M. Zhang, Y. Jiang, Y. Liu, H. Luo, C. Hao, P. Zeng and L. Zhang, Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Discov. Med. 23 (2017) 207–219.]Search in Google Scholar
[36. F. Hong, R.. Hansen, J. Yan D. Allendorf, J. Baran, G. Ostroff and G. Ross, Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells, Cancer Res. 63 (2003) 9023–9031; https://cancerres.aacrjournals.org/content/63/24/9023.long]Search in Google Scholar
[37. S. Modak, G. Koehne, A. Vickers, R. O’Reilly and N.-K. V. Cheung, Rituximab therapy of lymphoma is enhanced by orally administered (1®3),(1®4)-D-β-glucan, Leuk. Res. 29 (2005) 679–683; https://doi.org/10.1016/j.leukres.2004.10.00810.1016/j.leukres.2004.10.00815863209]Search in Google Scholar
[38. M. Thomas, P. Sadjadian, J. Kollmeier, J. Lowe, P. Mattson, J. R. Trout, M. Gargano, M. L. Patchen, R. Walsh, M. Beliveau, J. F. Marier, N. Bose, K. Gorden and F. Schneller III, A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer, Invest. New Drugs35 (2017) 345–358; https://doi.org/10.1007/s10637-017-0450-310.1007/s10637-017-0450-3541830728303530]Search in Google Scholar
[39. N. H. Segal, P. Gada, N. Senzer, M. Gargano, M. Patchen and L. Saltz, A phase II efficacy and safety, open-label, multicenter study of imprime PGG injection in combination with cetuximab in patients with stage IV KRAS-mutant colorectal cancer, Clin. Colorectal Cancer15 (2016) 222–227; https://doi.org/10.1016/j.clcc.2016.02.01310.1016/j.clcc.2016.02.013562151926975418]Search in Google Scholar
[40. H. Asai, H. Iijima, K. Matsunaga, Y. Oguchi, H. Katsuno and K. Maeda, Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling, Cancer Immunol. Immunother.57 (2008) 1647–1655; https://doi.org/10.1007/s00262-008-0498-110.1007/s00262-008-0498-118343922]Search in Google Scholar
[41. A. L. Engel, G. C. Sun, E. Gad, L. R. Rastetter, K. Strobe, Y. Yang, Y. Dang, M. L. Disis and H. Lu, Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant, Immunobiology218 (2013) 1468–1476; https://doi.org/10.1016/j.imbio.2013.05.00110.1016/j.imbio.2013.05.001378351923735481]Search in Google Scholar
[42. M. Kato, K. Hirose, M. Hakozaki, M. Ohno, Y. Saito, R. Izutani, J. Noguchi, Y. Hori, S. Okumoto, D. Kuroda, H. Nomura, S. Nishimatsu and H. Ohoyanagi, Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide, Cancer Immunol. Immunother.40 (1995) 152–156.10.1007/BF015173467728773]Search in Google Scholar
[43. C. B. Lau, C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. H. Chan and M. S. Chow, Cytotoxic activities of Coriolus versicolor (yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis, Life Sci.75 (2004) 797–808; https://doi.org/10.1016/j.lfs.2004.04.00110.1016/j.lfs.2004.04.00115183073]Search in Google Scholar
[44. C. Inatsuka, Y. Yang, E. Gad, L. Rastetter, M. L. Disis and H. Lu, Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK, Cancer Immunol. Immunother.62 (2013) 1335–1345; https://doi.org/10.1007/s00262-013-1436-410.1007/s00262-013-1436-4372762923685781]Search in Google Scholar
[45. C. J. Torkelson, E. Sweet, M. R. Martzen, M. Sasagawa, C. A. Wenner, J. Gay, A. Putiri and L. J. Standish, Phase 1 clinical trial of Trametes versicolor in women with breast cancer, ISRN Oncol. 2012 (2012) 251632 (7 pages); https://doi.org/10.5402/2012/25163210.5402/2012/251632336947722701186]Search in Google Scholar
[46. B. K. Sekhon, D. M. Sze, W. K. Chan, K. Fan, G. Q. Li, D. E. Moore and R. H. Roubin, PSP activates monocytes in resting human peripheral blood mononuclear cells: immunomodulatory implications for cancer treatment, Food Chem. 138 (2013) 2201–2209; https://doi.org/10.1016/j.food-chem.2012.11.00910.1016/j.foodchem.2012.11.009]Search in Google Scholar
[47. C. A. Wenner, M. R. Martzen, H. Lu, M. R. Verneris, H. Wang and J. W. Slaton, Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer, Int. J. Oncol. 40 (2012) 905–913; https://doi.org/10.3892/ijo.2011.129210.3892/ijo.2011.1292358455522159900]Search in Google Scholar
[48. Q. Y. Hu, H. Wang, W. M. Shen, X. R. Chen and M. Zou, Promoting effects of polysaccharide of Polysticius versicolor (L) FR. in C57BL/6J mice bearing melanoma B16, Chin. J. Antibiot. 6 (1988) 425–431.]Search in Google Scholar
[49. S. Xu, Y. H. Song, H. Li and H. B. Cai, Curative effect observation on advanced colorectal cancer by the treatment with PSP combined with XELOX regimen, Acta Univ. Med. Nanjing12 (2008) 1616–1618.]Search in Google Scholar
[50. H. Fritz, D. A. Kennedy, M. Ishii, D. Fergusson, R. Fernandes, K. Cooley and D. Seely, Polysaccharide K and Coriolus versicolor extracts for lung cancer: A systematic review, Integr. Cancer Ther. 14 (2015) 201–211; https://doi.org/10.1177/153473541557288310.1177/153473541557288325784670]Search in Google Scholar
[51. A. Knežević, M. Stajić, I. Sofrenić, T. Stanojković, I. Milovanović, V. Tešević and J. Vukojević, Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia, PLoS ONE13 (2018) e0203064 (18 pages); https://doi.org/10.1371/journal.pone.020306410.1371/journal.pone.0203064611837330169542]Search in Google Scholar
[52. L. Janjušević, B. Pejin, S. Kaišarević, S. Gorjanović, F. Pastor, K. Tešanović and M. Karaman, Trametes versicolor ethanol extract, a promising candidate for health-promoting food supplement, Nat. Prod. Res. 32 (2018) 963–967; https://doi.org/10.1080/14786419.2017.136648410.1080/14786419.2017.136648428817965]Search in Google Scholar
[53. C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. Chan and C. B. Lau, Differential anti-tumor activity of coriolus versicolor (yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells, Cancer Biol. Ther. 4 (2005) 638–644; https://doi.org/10.4161/cbt.4.6.172110.4161/cbt.4.6.172115908782]Search in Google Scholar
[54. D. Roca-Lema, O. Martinez-Iglesias, C. Fernández de Ana Portela, A. Rodríguez-Blanco, M. Valladares-Ayerbes, A. Díaz-Díaz, A. Casas-Pais, C. Prego and A. Figueroa, In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes versicolor and Grifola frondosa in colon cancer cells, Int. J. Med. Sci.16 (2019) 231–240; https://doi.org/10.7150/ijms.2881110.7150/ijms.28811636752230745803]Search in Google Scholar
[55. T.-C. Hsieh, J. Kunicki, Z. Darzynkiewicz and J. M. Wu, Effects of extracts of Coriolus versicolor (I’m-Yunity™) on cell-cycle progression and expression of interleukins-1β, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes, J. Altern. Complement. Med. 8 (2002) 591–602; https://doi.org/10.1089/10755530232082510110.1089/10755530232082510112470440]Search in Google Scholar
[56. N. Hirahara, M. Fujioka, T. Edamatsu, A. Fujieda, F. Sekine, T. Wada and T. Tanaka, Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells, Anticancer Res. 31 (2011) 2733–2738.]Search in Google Scholar
[57. T. S. Hattori, N. Komatsu, S. Shichijo and K. Itoh, Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa, Biomed. Pharmacother. 58 (2004) 226–230; https://doi.org/10.1016/j.biopha.2004.02.00410.1016/j.biopha.2004.02.00415183847]Search in Google Scholar
[58. C. Iguchi, Y. Nio, H. Takeda, K. Yamasawa, N. Hirahara, T. Toga, M. Itakura and K. Tamura, Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface, Anticancer Res. 21 (2001) 1007–1013.]Search in Google Scholar
[59. S. F. Yang, T. F. Zhuang, Y. M. Si, K. Y. Qi and J. Zhao, Coriolus versicolor mushroom polysaccha-rides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways, Mol. Immunol. 64 (2015) 144–151; https://doi.org/10.1016/j.molimm.2014.11.00710.1016/j.molimm.2014.11.00725480394]Search in Google Scholar
[60. H. Zhang, T. Morisaki, C. Nakahara, H. Matsunaga, N. Sato, F. Nagumo, J. Tadano and M. Katano, PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1, Oncogene22 (2003) 2088–2096; https://doi.org/10.1038/sj.onc.120631010.1038/sj.onc.120631012687011]Search in Google Scholar
[61. E. Jiménez-Medina, E. Berruguilla, I. Romero, I. Algarra, A. Collado, F. Garrido and A. Garcia-Lora, The immunomodulator PSK induces in vitro cytotoxic activity in tumor cell lines via arrest of cell cycle and induction of apoptosis, BMC Cancer8 (2008) Article ID 78 (10 pages); https://doi.org/10.1186/1471-2407-8-7810.1186/1471-2407-8-78229147118366723]Search in Google Scholar